Aveanna Healthcare Holdings Inc. · NASDAQ:AVAH
Aveanna Healthcare — Investor Presentation (August 2024)
20 slides from Aveanna Healthcare's investor presentation, Aug 9, 2024
Slide 1: Investor Presentation August 2024
Investor Presentation August 2024
Slide 2: Disclaimers and Forward-Looking Statements
Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase a
Slide 3: Transforming the Value of Homecare
Transforming the Value of Homecare Aveanna offers a leading, diversified homecare platform that delivers innovative care to pediatric, adult, and geriatric patients. With locations in 33 states, Aveanna has established a national footprint dedicated to high-quality clinical outcomes and enhanced val
Slide 4: Management team
Debbie Stewart Principal Accounting Officer Jeff Shaner Chief Executive Officer CEO of Aveanna since 2023 Instrumental in formation of Aveanna Healthcare Chief Operating Officer of Aveanna Healthcare since 2017 Chief Operating Officer of PSA Healthcare since 2015 Former SVP, President of Operations
Slide 5: Aveanna Overview
+ Aveanna Overview 2024 Guidance(1) Key Operating Statistics $1.985b+ Revenue 31.3% Gross Margin(2) $158m+ Adjusted EBITDA 334 Locations 33 States 26,500 Caregivers 41m Homecare Hours(3) 58 Preferred Payors ___________________________ 1. Consistent with prior practice, we are not providing guidance
Slide 6: Aveanna's Transformative Homecare Platform
Melia and Mom Heather Valerie JAR to think through and build out Aveanna's Transformative Homecare Platform Preferred Payor Partnerships Government Affairs Strategy Scaled National Platform Technology and Data Driven Results Reduction in Total Cost of Care Our advanced homecare platform positions us
Slide 7: Aveanna's Transformative Homecare Platform
Aveanna's Transformative Homecare Platform PDS Preferred Payors 22 2024 2023 Projected 14 7 State Rate Increases 19 Home Health Episodic Mix >70% 2024 2023 Value-based Agreements 8 5 2024 2023 Projected 2023 Projected 2024 Projected 10+ 62% 2022 2022 2022 2022 3 13 ~70% 2023 resulted in substantial
Slide 8: Aveanna's Transformative Homecare Platform: Long-term Growth Rate
Melia and Mom Heather Valerie Our future opportunity will continue to provide enhanced value that is driven by our significant investment in our value-based national homecare platform. Aveanna's Transformative Homecare Platform Value-based Organic Growth Risk-based Growth Core Organic Growth Scaled
Slide 9: Aveanna Business Segments
Valerie Melia and Mom Heather Aveanna Business Segments
Slide 10: Private Duty Services Segment
Private Duty Services Segment Financial Highlights Key Operating Statistics $1,631m Net Revenue1 26% – 28% Gross Margin2 3% – 5% Organic Growth Rate3 234 Locations 27 States 38,000 Patients on Service ~40% % of PP Volume Preferred Payors 19 Preferred Payor Partnerships underpinned by enhanced rates
Slide 11: Medical Solutions Segment
Medical Solutions Segment Financial Highlights Key Operating Statistics States we deliver to Patients on Service Preferred Payors $170m Net Revenue1 41% – 44% Gross Margin2 8% – 10% Organic Growth Rate3 37 31,000 3 Nutritional Support – Enteral Product, Equipment and Supplies Provided to Pediatric,
Slide 12: Home Health & Hospice Segment
Home Health & Hospice Segment Financial Highlights Key Operating Statistics Locations States Patients on Service Episodic Mix Preferred Payors $219m Net Revenue1 48% – 50% Gross Margin2 5% – 7% Organic Growth Rate3 84 15 13,500 36 Home Health Geriatric Patient Population Intermittent Services Shorte
Slide 13: Scaled Platform Built for Driving Growth and Enhancing Value
Scaled Platform Built for Driving Growth and Enhancing Value
Slide 14: Fragmented Home Care Markets Support Sustainable Growth
Fragmented Home Care Markets Support Sustainable Growth $20bn Legacy Pediatric Focus Personal Care $18.0bn Annual U.S. Healthcare Spend $4.5tn Therapy $6.0bn Enteral Nutrition $3.0bn Therapy $7.0bn Private Duty Nursing $10.0bn Hospice $23.0bn $99bn Addressable Adult Opportunity TAM annual growth fro
Slide 15: Q2 2024 Financial Performance: Summary Results
Q2 2024 Financial Performance: Summary Results PDS Q2 2024 revenue growth of 8.0% from Q2 2023, driven by 10.3 million hours of care or 4.8% YOY volume increase MS Q2 2024 revenue growth of 9.3% from Q2 2023, driven by strong volume growth of 10.6% HHH Q2 2024 gross margin growth of 9.3% from Q2 202
Slide 16: Financial Performance: Capital Structure
Financial Performance: Capital Structure Liquidity of over $268.9m, comprised of the following: $47.7m cash on balance sheet $168.2m revolver availability $53.0m securitization availability Undrawn revolver at the end of Q2 $32m in outstanding letters of credit at the end of Q1 Total variable rate d
Slide 17: Path Forward: Strategic and Operational Focus on Driving Shareholder Value
Path Forward: Strategic and Operational Focus on Driving Shareholder Value Value-based Growth Enhanced Capital Structure Core Organic Growth
Slide 18: Appendix
SS aveanna healthcare Appendix
Slide 19: Reconciliation of Net Loss to Adjusted EBITDA
Reconciliation of Net Loss to Adjusted EBITDA ___________________________ 1-8: Please see our earnings release posted on November 9, 2023 for further description of the nature of these items
Slide 20: Reconciliation of Net Cash to Free Cash Flow
Reconciliation of Net Cash (Used in) Provided by Operating Activities to Free Cash Flow
Aveanna Healthcare Holdings — Investor Presentation (August 2024) on 6ix